RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL

Catalog number BNC472765-100

Price for BNC472765-100

Size / count 1x 100 µL

About this product

RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of human tumor cells. Overexpression of RAD51 protein in tumor cells renders them resistant against cytotoxic drugs like Cisplatin. RAD51 interacts with BRCA1 and BRCA2 to influence subcellular localization and cellular response to DNA damage. BRCA2 inactivation may be a key event leading to genomic instability and tumorigenesis from deregulation of RAD51. High-level expression of RAD51 has been observed in a variety of human malignancies. RAD51 overexpression correlates with histological grading of the tumor in invasive ductal mammary carcinoma. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC472765-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: RCA1/BRCA2 containing complex; subunit 5; BRCC5; DNA repair protein RAD51; FANCR; HsT16930; MRMV2; RAD51; RAD51 recombinase; RAD51A; RECA; RecA like protein; Recombination protein A
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: RAD51
Gene ID: 5888
NCBI Gene ID: 631709
UniProt: Q06609
Swiss Prot: Q06609
Host: Mouse
Species Reactivity: Human
Reactivity: RAD51
Immunogen: Recombinant fragment of human RAD51 protein (around aa 1-134) (exact sequence is proprietary)
Target Antigen: RAD51
Clonality: Monoclonal
Clone: RAD51/2765
Type: Primary
Source: Animal
Origin: Animal
Positive Control: HeLa or MCF-7 cells. Colon or breast Carcinoma.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 37 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG2b, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF647

Frequently Asked Questions

What is the catalog number for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL?

The catalog number for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is BNC472765-100.

What sizes are available for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL in stock?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL?

Estimated delivery time for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL?

The safety data sheet for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02a7061270361e1062ec/msds/bnc472765-100.pdf.

What is RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF647 conjugate, 0.1mg/mL used for?

Is this product suitable for live cell imaging?

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Is this product covered by a money-back guarantee?

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Can this product be used for diagnostic or therapeutic purposes?

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.